Form D · Biotechnology
SMSbiotech, Inc.
San Marcos, CA · CIK 0002075778
Offering snapshot reported Oct 15, 2025 · SEC filing
- Reported sold
- Yet to sell Offering amount: $15.8M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 15, 2025 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-560954
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| N/A | None |
Source: Form D, filed Oct 15, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mohamed Diab | Director |
| Harry Friedman | Director, Executive |
| Ghassan Kassab | Director |
| Joseph Kiani | Director |
| Abdulkader Rahmo, Ph.D. | Director, Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1825 Diamond Street Suite 101
San Marcos, CA, 92078
San Marcos, CA, 92078